Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Millennium Pharmaceuticals, Inc. (MLNM) -- Ignore unavailable to you. Want to Upgrade?

To: Richard Haugland who wrote (183)	4/21/1998 6:22:00 AM
From: Richard Haugland	Read Replies (1) \| Respond to of 3044

Millennium Pharmaceuticals, Inc. and Hoffmann-La Roche Achieve Research Milestone in Obesity Gene to Enter High Throughput Drug Screening, Triggering Payment to Millennium biz.yahoo.com The achievement of this milestone triggers a payment to Millennium and represents the most recent scientific advancement in Millennium's obesity program. Financial terms and the identity of the target were not disclosed. That's what we like to hear. Second announcement of this type in a week or so.